Theratechnologies Shares Surge Premarket on Deal to Go Private

Dow Jones

Jul 03

By Colin Kellaher

Shares of Theratechnologies rose sharply in premarket trading Thursday after the biopharmaceutical company agreed to be acquired by privately held pharmaceutical and nutraceutical products maker Future Pak for up to $254 million.

Theratechnologies late Wednesday said Future Pak will pay an initial $3.01 a share in cash for the Montreal company, a nearly 28% premium to Wednesday's closing price of $2.36 for its U.S.-listed shares and more than double its closing price of $1.33 on April 10, the day before Future Pak announced its pursuit of the company.

Theratechnologies investors will also receive contingent value rights worth up to an additional $1.19 a share tied to certain profit milestones, which could bring the total transaction consideration to $4.20 a share, or $254 million.

U.S.-listed shares of Theratechnologies were recently up 32% at $3.12 in premarket trading.

The deal is slated to close by the end of November.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

July 03, 2025 06:03 ET (10:03 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2548089628"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2548089628\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2548089628?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-03 18:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2548089628","market":"hk","top_or_hot":-1,"title":"Theratechnologies Shares Surge Premarket on Deal to Go Private","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of Theratechnologies rose sharply in premarket trading Thursday after the biopharmaceutical company agreed to be acquired by privately held pharmaceutical and nutraceutical products maker Future Pak for up to $254 million. \n</p>\n<p>\n  Theratechnologies late Wednesday said Future Pak will pay an initial $3.01 a share in cash for the Montreal company, a nearly 28% premium to Wednesday's closing price of $2.36 for its U.S.-listed shares and more than double its closing price of $1.33 on April 10, the day before Future Pak announced its pursuit of the company. \n</p>\n<p>\n  Theratechnologies investors will also receive contingent value rights worth up to an additional $1.19 a share tied to certain profit milestones, which could bring the total transaction consideration to $4.20 a share, or $254 million. \n</p>\n<p>\n  U.S.-listed shares of Theratechnologies were recently up 32% at $3.12 in premarket trading. \n</p>\n<p>\n  The deal is slated to close by the end of November. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 03, 2025 06:03 ET (10:03 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Theratechnologies Shares Surge Premarket on Deal to Go Private</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTheratechnologies Shares Surge Premarket on Deal to Go Private\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-07-03 18:03</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of Theratechnologies rose sharply in premarket trading Thursday after the biopharmaceutical company agreed to be acquired by privately held pharmaceutical and nutraceutical products maker Future Pak for up to $254 million. \n</p>\n<p>\n  Theratechnologies late Wednesday said Future Pak will pay an initial $3.01 a share in cash for the Montreal company, a nearly 28% premium to Wednesday's closing price of $2.36 for its U.S.-listed shares and more than double its closing price of $1.33 on April 10, the day before Future Pak announced its pursuit of the company. \n</p>\n<p>\n  Theratechnologies investors will also receive contingent value rights worth up to an additional $1.19 a share tied to certain profit milestones, which could bring the total transaction consideration to $4.20 a share, or $254 million. \n</p>\n<p>\n  U.S.-listed shares of Theratechnologies were recently up 32% at $3.12 in premarket trading. \n</p>\n<p>\n  The deal is slated to close by the end of November. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 03, 2025 06:03 ET (10:03 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"THTX","symbol_name":"Theratechnologies, Inc.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2548089628","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2548089628","pubTimestamp":1751536980,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Theratechnologies rose sharply in premarket trading Thursday after the biopharmaceutical company agreed to be acquired by privately held pharmaceutical and nutraceutical products maker Future Pak for up to $254 million.Theratechnologies late Wednesday said Future Pak will pay an initial $3.01 a share in cash for the Montreal company, a nearly 28% premium to Wednesday's closing price of $2.36 for its U.S.-listed shares and more than double its closing price of $1.33 on April 10, the day before Future Pak announced its pursuit of the company.Theratechnologies investors will also receive contingent value rights worth up to an additional $1.19 a share tied to certain profit milestones, which could bring the total transaction consideration to $4.20 a share, or $254 million.U.S.-listed shares of Theratechnologies were recently up 32% at $3.12 in premarket trading.The deal is slated to close by the end of November.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"THTX":"Theratechnologies, Inc.","BK4139":"生物科技"},"translate_title":"Theratechnologies股价因私有化交易盘前飙升","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"THTX":0.9},"content_text":"By Colin Kellaher \n\n\n \n\n\n  Shares of Theratechnologies rose sharply in premarket trading Thursday after the biopharmaceutical company agreed to be acquired by privately held pharmaceutical and nutraceutical products maker Future Pak for up to $254 million. \n\n\n  Theratechnologies late Wednesday said Future Pak will pay an initial $3.01 a share in cash for the Montreal company, a nearly 28% premium to Wednesday's closing price of $2.36 for its U.S.-listed shares and more than double its closing price of $1.33 on April 10, the day before Future Pak announced its pursuit of the company. \n\n\n  Theratechnologies investors will also receive contingent value rights worth up to an additional $1.19 a share tied to certain profit milestones, which could bring the total transaction consideration to $4.20 a share, or $254 million. \n\n\n  U.S.-listed shares of Theratechnologies were recently up 32% at $3.12 in premarket trading. \n\n\n  The deal is slated to close by the end of November. \n\n\n \n\n\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 03, 2025 06:03 ET (10:03 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}